My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Menitorix powder and solvent for solution for injection. Haemophilus type b and Meningococcal group C conjugate vaccine



GlaxoSmithKline (Ireland) LimitedPA1077/116/001

Main Information

Trade NameMenitorix powder and solvent for solution for injection. Haemophilus type b and Meningococcal group C conjugate vaccine
Active SubstancesConjugate of haemophilus influenzae type b capsular polysaccharide (polyribosylribitol phosphate) and tetanus
Conjugate of neisseria meningitides c capsular polysaccharide and tetanus toxoid (mean tt/ps ratio :1)
Dosage FormPowder and solvent for solution for injection
Licence HolderGlaxoSmithKline (Ireland) Limited
Licence NumberPA1077/116/001

Group Information

ATC CodeJ07AG53 hemophilus influenzae B, combinations with meningococcus C, conjugated

Status

License statusAuthorised
Licence Issued15/02/2008
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print